Luminex Corporation (LMNX) Stake Increased by Blair William & Co. IL

Blair William & Co. IL boosted its position in Luminex Corporation (NASDAQ:LMNX) by 1.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 207,219 shares of the medical instruments supplier’s stock after buying an additional 3,750 shares during the period. Blair William & Co. IL owned about 0.47% of Luminex Corporation worth $4,376,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of LMNX. Mason Street Advisors LLC boosted its position in Luminex Corporation by 0.5% in the first quarter. Mason Street Advisors LLC now owns 8,713 shares of the medical instruments supplier’s stock worth $160,000 after buying an additional 46 shares during the period. McQueen Ball & Associates Inc. boosted its position in Luminex Corporation by 0.3% in the second quarter. McQueen Ball & Associates Inc. now owns 29,095 shares of the medical instruments supplier’s stock worth $614,000 after buying an additional 95 shares during the period. Creative Planning boosted its position in Luminex Corporation by 5.4% in the first quarter. Creative Planning now owns 9,256 shares of the medical instruments supplier’s stock worth $170,000 after buying an additional 474 shares during the period. BNP Paribas Arbitrage SA boosted its position in Luminex Corporation by 6.7% in the first quarter. BNP Paribas Arbitrage SA now owns 7,780 shares of the medical instruments supplier’s stock worth $143,000 after buying an additional 489 shares during the period. Finally, Sei Investments Co. boosted its position in Luminex Corporation by 10.9% in the first quarter. Sei Investments Co. now owns 5,946 shares of the medical instruments supplier’s stock worth $110,000 after buying an additional 582 shares during the period. Institutional investors and hedge funds own 73.36% of the company’s stock.

Shares of Luminex Corporation (NASDAQ:LMNX) opened at 19.09 on Wednesday. The company has a market cap of $841.32 million, a PE ratio of 59.10 and a beta of 0.29. Luminex Corporation has a 12 month low of $17.64 and a 12 month high of $23.62. The stock has a 50 day moving average of $20.25 and a 200-day moving average of $19.60.

Luminex Corporation (NASDAQ:LMNX) last posted its quarterly earnings data on Monday, August 7th. The medical instruments supplier reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.11. The company had revenue of $76.50 million during the quarter, compared to analysts’ expectations of $75.45 million. Luminex Corporation had a return on equity of 4.81% and a net margin of 4.72%. Luminex Corporation’s revenue for the quarter was up 19.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 earnings per share. Equities analysts forecast that Luminex Corporation will post $0.54 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Luminex Corporation (LMNX) Stake Increased by Blair William & Co. IL” was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another website, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The correct version of this piece can be accessed at https://transcriptdaily.com/2017/08/23/luminex-corporation-lmnx-stake-increased-by-blair-william-co-il.html.

A number of research firms have commented on LMNX. BidaskClub cut shares of Luminex Corporation from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 9th. TheStreet cut shares of Luminex Corporation from a “b” rating to a “c+” rating in a research report on Monday, August 7th. Zacks Investment Research raised shares of Luminex Corporation from a “hold” rating to a “buy” rating and set a $23.00 price objective for the company in a research report on Monday, July 17th. ValuEngine cut shares of Luminex Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $21.00 price objective on shares of Luminex Corporation in a research report on Friday, June 9th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Luminex Corporation presently has a consensus rating of “Hold” and an average target price of $21.60.

In related news, Director G Walter Loewenbaum II sold 25,000 shares of the company’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $20.07, for a total transaction of $501,750.00. Following the completion of the sale, the director now owns 713,896 shares in the company, valued at $14,327,892.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 6.90% of the stock is currently owned by corporate insiders.

About Luminex Corporation

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments.

Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corporation (NASDAQ:LMNX).

Institutional Ownership by Quarter for Luminex Corporation (NASDAQ:LMNX)

Receive News & Ratings for Luminex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply